JNCCN 360 - MM - Ongoing CE Activities

Editors:

Shaji K. Kumar, MD

Prashant Kapoor, MD, FACP

Advertisement

Advertisement

Ongoing CE Activities

Recorded Presentations from the NCCN 2017 Nursing Forum: Advancing Oncology Nursing in Hematologic Malignancies

Autologous Stem Cell Transplantation in Multiple Myeloma: Who, When, and How?

Clinical Investigator Perspectives on the Current and Future Management of Multiple Myeloma

Eliminating Disparities in Relapsed/Refractory Multiple Myeloma Care

Exploring the Current and Future Role of BCMA-Directed Therapy in the Management of Multiple Myeloma

Financial Toxicity in the Care of Patients With Hematologic Malignancies

Managing Myeloma: Where We Are, Where We’re Going, and Where We Should Be Going (Time to Choose Sides!)

NCCN Guidelines Insights, Multiple Myeloma, Version 3.2022

Oncology Today with Dr Neil Love: Current Role of Minimal Residual Disease Assessment in the Management of Multiple Myeloma and Chronic Lymphocytic Leukemia

Oncology Today with Dr Neil Love: Key Presentations on Multiple Myeloma from ASH 2021

Redefining Value Propositions and Managed Care Considerations in Multiple Myeloma

Relapsing/Refractory Multiple Myeloma in a High-Risk Patient: Efficacy With Monoclonal Antibody Therapy as Part of Triple Therapy

Role of Proteasome Inhibitor Therapy in a Patient with High-Risk Relapsing Multiple Myeloma

The Role of Maintenance Therapy in Multiple Myeloma

Sections

NCCN Resources

Copyright © 2022 National Comprehensive Cancer Network, All Rights Reserved

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.